Examkin

Soru

Zorluk: ZorDiagnostic Workup and Test Sequencing

A 49-year-old man with a history of recurrent severe dyspepsia and chronic watery diarrhea is admitted to the hospital due to an episode of melena. He has been taking high-dose omeprazole for the past year with minimal relief of his abdominal symptoms. Esophagogastroduodenoscopy performed upon admission reveals prominently thickened gastric folds, severe erosive esophagitis, and multiple ulcerations extending into the descending duodenum and proximal jejunum. Rapid urease testing for Helicobacter pylori is negative. The physician suspects a neuroendocrine tumor as the underlying cause of the patient's presentation.

Arrange the following diagnostic steps in the most appropriate sequential order to establish the diagnosis and formulate a definitive management plan, from the initial biochemical screening test to the final invasive localization procedure.

  1. 1Measurement of fasting serum gastrin level and gastric pH
  2. 2Intravenous secretin stimulation test
  3. 3Gallium-68 DOTATATE positron emission tomography-computed tomography (PET/CT)
  4. 4Endoscopic ultrasound (EUS) of the peripancreatic region and duodenum

Cevap

The proper sequencing of diagnostic steps for suspected Zollinger-Ellison syndrome requires initial biochemical screening with fasting serum gastrin and gastric pH, followed by a confirmatory secretin stimulation test. After biochemical diagnosis, non-invasive localization using somatostatin receptor imaging (Ga-68 DOTATATE PET/CT) is performed. Finally, invasive localization with endoscopic ultrasound is utilized for precise pre-operative surgical mapping.
The algorithm for diagnosing and managing a suspected gastrinoma strictly separates biochemical confirmation from anatomical localization. Step 1: Biochemical screening always begins with fasting serum gastrin and gastric pH to confirm acid-hypersecretory hypergastrinemia. Step 2: Because many patients have non-diagnostic gastrin elevations (110-1000 pg/mL), a secretin stimulation test is the requisite confirmatory step. Step 3: Once biochemically confirmed, non-invasive anatomical localization is performed, currently best achieved with somatostatin receptor imaging such as Ga-68 DOTATATE PET/CT. Step 4: If functional imaging is negative, or for high-resolution presurgical planning of tumors in the duodenal wall or pancreatic head, endoscopic ultrasound (EUS) is the final invasive localization step.

Adım Adım Çözüm

1
Initial Biochemical Screening
Measurement of fasting serum gastrin level and gastric pH.
To identify hypergastrinemia in the setting of an acidic stomach, definitively differentiating it from appropriate secondary hypergastrinemia due to achlorhydria.
2
Confirmatory Testing
Intravenous secretin stimulation test.
To distinguish a gastrinoma (which will paradoxically increase gastrin secretion in response to secretin) from other causes of hypergastrinemia, particularly when initial gastrin levels are equivocal.
3
Non-Invasive Localization
Gallium-68 DOTATATE PET/CT.
To localize the primary neuroendocrine tumor and evaluate for distant metastatic disease using highly sensitive functional somatostatin receptor imaging.
4
Invasive Localization and Surgical Planning
Endoscopic ultrasound (EUS) of the peripancreatic region and duodenum.
To pinpoint small submucosal tumors located within the gastrinoma triangle that might be missed by non-invasive imaging, and to assess relationship to local vasculature prior to surgical exploration.

Anahtar Kavram

Diagnostic sequencing for Zollinger-Ellison Syndrome (Gastrinoma)
Bu soruyu puanla

Konular

Diagnostic Workup and Test Sequencing

Bu konudan daha fazla soru